-
MDU Resources Donates $500,000 to Support Pandemic Response Efforts
prnewswire
April 16, 2020
MDU Resources Group, Inc. announced today that it is donating $500,000 to a variety of organizations to support coronavirus relief efforts.
-
China approves two experimental coronavirus vaccines to enter clinical trials
expresspharma
April 16, 2020
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
-
China strengthens epidemic control along border, expands coronavirus infection testing in key regions
chinadaily
April 13, 2020
The city of Suifenhe, at the China-Russia border in Northeast China's Heilongjiang province, will build a temporary hospital as pressure mounts to stem the flow of imported novel coronavirus cases.
-
BARDA funds OraSure's home spit test for coronavirus infections
fiercebiotech
April 13, 2020
The U.S. federal government’s Biomedical Advanced Research and Development Authority, known as BARDA, has funded the development of a rapid coronavirus test that can be self-administered at home.
-
Pfizer identifies lead coronavirus drug candidate
pharmaceutical-technology
April 13, 2020
Pfizer has announced progress in its research programme to develop antivirals and vaccine for the Covid-19 coronavirus infection.
-
Vaccines Industry Witnesses Essential Demand in Efforts to Safeguard the Population Against COVID-19
prnewswire
April 10, 2020
ResearchAndMarkets.com identifies Unified Communications as one of the key industries seeing increased demand due to the Coronavirus pandemic.
-
Coronavirus: Disease exposure the biggest challenge to healthcare service professionals
pharmaceutical-technology
April 10, 2020
Exposure to the disease and lack of enough critical medical devices are the biggest challenges facing healthcare professionals during the coronavirus pandemic, found a Verdict poll.
-
AstraZeneca begins efforts to identify antibodies against Covid-19
pharmaceutical-technology
April 10, 2020
AstraZeneca has begun research efforts focused on the identification and development of antibody therapies against Covid-19 coronavirus infection.
-
Oxford Biomedica joins consortium for coronavirus vaccine
pharmaceutical-technology
April 09, 2020
UK-based gene and cell therapy group Oxford Biomedica has become part of a consortium focussed on the development, scale-up and production of a Covid-19 coronavirus vaccine candidate.
-
Montefiore, Einstein Begin Coronavirus Treatment Trial
americanpharmaceuticalreview
April 08, 2020
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.